news
New anti-cancer stem cell compound in development
7 May 2015 | By Victoria White
Cardiff University scientists have developed a novel anti-cancer stem cell agent capable of targeting aggressive tumour forming cells...
List view / Grid view
Stem Cells
news
Scientists identify key receptors behind development of acute myeloid leukaemia
30 April 2015 | By Victoria White
Researchers have found that ITIM - receptors are important to the development of acute myeloid leukaemia (AML), providing a target for potential therapies...
news
CiRA and Takeda to collaborate on iPS Cell Research
17 April 2015 | By Victoria White
Takeda and CiRA to work together to develop clinical applications of induced pluripotent stem cells in areas such as diabetes mellitus and immunotherapy...
article
The promise of induced pluripotent stem cells for liver disease, toxicology and drug discovery
We discuss the steps required for differentiating human pluripotent stem cells into hepatocyte-like cells, and how long this process takes and the quality control measures needed...
news
AstraZeneca to collaborate with the HSCI in search for new diabetes treatments
25 March 2015 | By Victoria White
AstraZeneca to collaborate with the HSCI to adapt a technique that creates human beta cells from stem cells to search for new treatments for diabetes...
article
Meet the editorial board members who influenced the Spring 2015 issue
Editor Caroline Richards talks about the editorial board members who have influenced the content coming up in the latest issue of Drug Target Review, available in April 2015...
news
A vaccine against placental malaria made with ExpreS2ion Biotechnologies’ protein expression technology, ExpreS2, is ready to start human tests in Germany and Benin
20 March 2015 | By Victoria White
ExpreS2ion Biotechnologies announce the release by its partners at University of Copenhagen of a vaccine against placental malaria for testing in humans...
news
Combination cell-gene therapy for lung cancer to be tested in UK patients
6 March 2015 | By The Medical Research Council
A pioneering new combined cell-gene therapy to treat lung cancer will be tested in NHS patients this year, after receiving £2m of Biomedical Catalyst funding from the Medical Research Council...
news
‘Stem cell’ test could identify most aggressive breast cancers
4 March 2015 | By The Institute of Cancer Research
Testing breast cancer cells for how closely they resemble stem cells could identify women with the most aggressive disease, a new study suggests...
news
Nobel Laureate’s stem cell company Cell Therapy Limited sets new crowdfunding record raising £691,000 on Crowdcube
9 February 2015 | By Cell Therapy Ltd
UK biotech company Cell Therapy Limited has raised over £691,000 on Crowdcube to fund its breakthrough stem cell medicine, Heartcel™, which regenerates heart muscle to treat heart failure...
news
Key US patents granted for GPCR-focused drug discovery platform arising from pioneering research and translational expertise at MRC and MRC Technology
17 December 2014 | By MRC Technology
Structure-based drug discovery platform targets challenging GPCRs linked to human disease...
news
Seahorse Bioscience and University of Alabama partner to advance validation of bioenergetic health index for personalized medicine
15 October 2014 | By Seahorse Bioscience
Seahorse Bioscience and the University of Alabama at Birmingham announced that they have entered into a partnership to study the bioenergetic health of cells in cryo-preserved blood – a step that will ultimately produce a first-of-its-kind clinical test of metabolic bioenergetic health...
news
New study shows UK public are largely unaware of stem cells as the potential uses are still being realised
9 October 2014 | By On Broadcast
18 years since the first cord blood transplants were performed in the UK, public knowledge on this life-saving process is still sorely lacking. A study of over 4,000 people found that nearly a third (32%) of Britons did not know you can store umbilical cord blood and tissue, while the…
article
Screening In-Depth Focus 2014
7 May 2014 | By Kenji Schorpp, Christophe Antczak, Balajee Somalinga, Hakim Djaballah
In this Screening In-Depth Focus: Kenji Schorpp looks at targeting the ubiquitin-proteasome system, and experts from Memorial Sloan-Kettering Cancer Center discuss a high content assay opportunity to measure cellular stress response using heat shock proteins...
news
Promega interviewed at SLAS 2014
27 February 2014 | By Freddy White, Drug Target Review
Michael Bjerke, Promega's Global Product Manager, Detection, speaks to Freddy White at SLAS 2014.